Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Alzheimer’s, There’s A Lot Of Room Under The Radar

This article was originally published in Pharmaceutical Approvals Monthly

Executive Summary

At the Alzheimer’s Association International Conference in July, a number of companies reported findings alongside headliners Lilly, Merck and AstraZeneca.

Advertisement

Related Content

Vitae Obtains Proof-Of-Mechanism Data For BACE Inhibition In Alzheimer’s
Vitae Obtains Proof-Of-Mechanism Data For BACE Inhibition In Alzheimer’s
Alzheimer’s Conference Marked By Diversity Of Approaches
Lilly Ends Trial Of BACE Inhibitor For Alzheimer’s, But Says Class-Wide Safety Effect Unlikely
Efficacy Signal For Lilly’s Solanezumab Stirs The Alzheimer’s Pot
Beyond Bapi: Alzheimer’s Pipeline Runs Deep

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS005536

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel